SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense of $0 in Q1 FY2026

Q1 FY2026 income tax expense was $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Income Tax Expense vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Income Tax Expense for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$119.01M USD-39.9%+12.0%1.1%
BLCOBausch + Lomb CorporationLTM Jun 2026$98M USD+174.2%-15.5%1.8%
STAASTAAR Surgical CompanyLTM Apr 2026$1.47M USD-84.9%—0.5%
RXSTRxSight, Inc.LTM Mar 2026$54K USD-8.5%+94.3%0.0%
SGPSpyGlass Pharma, Inc. Common StockFY2025$0 USD———
OCULOcular Therapeutix, Inc.LTM Mar 2026$0 USD——0.0%
SGHTSight Sciences, Inc.LTM Mar 2026-$20K USD-107.7%-40.3%0.0%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026-$43K USD-147.8%—0.6%
OCSOculis Holding AGLTM Mar 2026-CHF 291.8K CHF-59.5%+47.8%57.9%
GKOSGlaukos CorporationLTM Jun 2026-$4.79M USD-851.2%—0.8%
Peer median (excluding SGP) —-72.2%+12.0%0.6%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.